Literature DB >> 10182105

Vitrectomy for diabetic macular edema associated with a taut premacular posterior hyaloid.

S D Pendergast1.   

Abstract

Diabetic macular edema represents an important cause of visual loss in patients with diabetes. Although the pathophysiology of diabetic macular edema is unknown, various demographic, metabolic, and systemic factors have been implicated. More recently, the role of the posterior vitreomacular relationship has been evaluated, and studies suggest that posterior vitreous separation confers a protective effect on the development of diabetic macular edema. Furthermore, vitreomacular separation occurring in eyes with diabetic macular edema may facilitate spontaneous resolution of the edema and improvement in visual acuity. In a subset of patients, diffuse diabetic macular edema can result from a taut and condensed posterior hyaloid and often responds poorly to focal or grid-pattern laser photocoagulation. Previous studies have reported favorable results following vitrectomy and peeling of the posterior hyaloid in such cases.

Entities:  

Mesh:

Year:  1998        PMID: 10182105     DOI: 10.1097/00055735-199806000-00013

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  6 in total

1.  Factors predicting outcome of vitrectomy for diabetic macular oedema: results of a prospective study.

Authors:  S P Shah; M Patel; D Thomas; S Aldington; D A H Laidlaw
Journal:  Br J Ophthalmol       Date:  2006-01       Impact factor: 4.638

2.  Visual acuity comparison of vitrectomy with and without internal limiting membrane removal in the treatment of diabetic macular edema.

Authors:  Mehmet Bahadir; Aylin Ertan; Ozgür Mertoğlu
Journal:  Int Ophthalmol       Date:  2006-06-19       Impact factor: 2.031

3.  Pars plana vitrectomy and removal of the internal limiting membrane in the treatment of chronic macular oedema.

Authors:  Remzi Avci; Berkant Kaderli; Berrin Avci; Saban Simsek; Mehmet Baykara; Zeynep Kahveci; Oner Gelisken; Ahmet Ali Yucel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-06-22       Impact factor: 3.117

Review 4.  Diabetic macular edema: New promising therapies.

Authors:  Hanan N Al Shamsi; Jluwi S Masaud; Nicola G Ghazi
Journal:  World J Diabetes       Date:  2013-12-15

5.  Diabetic macular edema: therapeutic options.

Authors:  Amol D Kulkarni; Michael S Ip
Journal:  Diabetes Ther       Date:  2012-03-06       Impact factor: 2.945

Review 6.  Complications of Macular Peeling.

Authors:  Mónica Asencio-Duran; Beatriz Manzano-Muñoz; José Luis Vallejo-García; Jesús García-Martínez
Journal:  J Ophthalmol       Date:  2015-09-03       Impact factor: 1.909

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.